Benfluorex, sejenis ubat diabetic, telah digunakan meluas di sesetengah negara, telah dikatikan dengan lebih 500 kematian dan sekurang-kurangnya 3500 kes admisi hospital akibat penyakit injap jantung di Perancis. Makluman ini didedahkan oleh organisasi insurans kesihatan kebangsaan Perancis, CNAM. Pada November 2009, ubat ini ditarik daripada pasaran dan Suruhanjaya Eropah telah mengeluarkan keputusan yang sama pada Jun 2010. Di Malaysia pula, Benfluorex atau nama dagangnya Mediaxal telah ditarik balik pada lewat 2010. Versi generiknya (buatan Malaysia), Axal pun telah ditarik balik. Sekiranya anda masih mengambil ubat ini, sila berhenti segera!!
Benfluorex, a diabetic drug, which has been used widely to treat obesity in some countries has been linked to over 500 deaths and a minimum of 3500 hospitalizations for valvular heart diseases in France. This report was recently exposed by the French national health-insurance organization CNAM. Translated and adapted from theheart.org French edition) Saint-Denis, France. The report also warned that a significant correlation existed between an increase in daily doses of the drug with a greater likelihood of valvular disease or death. In November 2009, the drug was pulled off the market due to its grave effects on the heart.This drug, with its trade name Mediaxal, has also been widely used as an appetite suppressant to counter obesity.The European Commission issued a decision on 14/06/2010. A local company in Malaysia, Duopharma, manufactured its generic version, Axal and has withdrawn it from the local market, in response to a Health Ministry circular. From my observation, this drug is still available in our local market.
No comments:
Post a Comment